⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL637556 | 1.00 | — | — | |
| SCHEMBL288772 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL2651958 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL29048202 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL20451186 | 0.97 | — | — | |
| SCHEMBL10626484 | 0.84 | S1PR2 (0.47) | — | |
| SCHEMBL288510 | 0.82 | SLC22A6 (0.50) | — | |
| SCHEMBL21527758 | 0.80 | LDHA (0.35) | — | |
| SCHEMBL326176 | 0.80 | CACNA2D1 (0.42) | — | |
| Acetic Acid SCHEMBL2595033 | 0.80 | SLC22A6 (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 665 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119233657-A | Perovskite solar cell, preparation method thereof and photovoltaic module | 天合光能股份有限公司 | 2024-12-31 | — | — | CN | claimed |
| CN-119082054-A | Novel dipeptide synthetase and application thereof | 上海交通大学 | 2024-12-06 | — | — | CN | claimed |
| EP-4464320-A1 | PHARMACEUTICAL COMPOSITION COMPRISING NEUROKININ-1 ANTAGONIST PRODRUG COMPOUND | Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) | 2024-11-20 | — | — | EP | claimed |
| CN-118510509-A | Pharmaceutical composition comprising a neurokinin-1 antagonist prodrug compound | 江苏恒瑞医药股份有限公司 | 2024-08-16 | — | — | CN | claimed |
| WO-2024128542-A1 | CUTTING OIL COMPOSITION | 와이씨켐 주식회사 | 2024-06-20 | — | — | WO | claimed |
| WO-2023134725-A1 | PHARMACEUTICAL COMPOSITION COMPRISING NEUROKININ-1 ANTAGONIST PRODRUG COMPOUND | 江苏恒瑞医药股份有限公司 | 2023-07-20 | — | — | WO | claimed |
| CN-115295078-A | Development and application of amino lyase mutant | 宁波酶赛生物工程有限公司 | 2022-11-04 | — | — | CN | claimed |
| CN-114797418-A | Novel flue gas deep dust removal, desulfurization and denitrification process and efficient energy-saving equipment system | 北京紫光英力化工技术有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-111388657-A | Pharmaceutical composition containing bivalirudin and preparation method thereof | 江苏恒瑞医药股份有限公司 | 2020-07-10 | — | — | CN | claimed |
| US-20190105392-A1 | Caspofungin Acetate Formulations | FRESENIUS KABI USA LLC (US) | 2019-04-11 | — | — | US | claimed |
| EP-0594540-B1 | Antiretroviral acyl compounds | CIBA GEIGY AG (CH) | 1998-04-01 | — | — | EP | claimed |
| US-5670497-A | RETROVIRAL PROTEASE INHIBITORS | CIBA-GEIGY CORPORATION (US) | 1997-09-23 | — | — | US | claimed |
| CN-1132756-A | Antiviral ethers of aspartate protease substrate isosteres | CIBA GEIGY AG (CH) | 1996-10-09 | — | — | CN | claimed |
| EP-0604368-B1 | Anti retroviral hydrazine derivatives | CIBA GEIGY AG (CH) | 1996-09-18 | — | — | EP | claimed |
| WO-1996016980-A1 | MORPHOLINOETHYLAMIDE DERIVATIVES | NOVARTIS AG (CH) | 1996-06-06 | — | — | WO | claimed |
| EP-0708760-A1 | CYCLIC HYDRAZINE COMPOUNDS | Novartis AG (CH) | 1996-05-01 | — | — | EP | claimed |
| EP-0708085-A2 | Antiviral ethers of aspartate protease substrate isosteres | CIBA-GEIGY AG (CH) | 1996-04-24 | — | — | EP | claimed |
| WO-1995002582-A1 | CYCLIC HYDRAZINE COMPOUNDS | CIBA-GEIGY AG (CH) | 1995-01-26 | — | — | WO | claimed |
| CN-1093701-A | Antiretroviral hydrazine derivative | CIBA GEIGY AG (CH) | 1994-10-19 | — | — | CN | claimed |
| CN-1089606-A | Antiretroviral acyl compounds | CIBA GEIGY AG (CH) | 1994-07-20 | — | — | CN | claimed |